GenomeNet

Database: UniProt
Entry: AT2B4_RAT
LinkDB: AT2B4_RAT
Original site: AT2B4_RAT 
ID   AT2B4_RAT               Reviewed;        1203 AA.
AC   Q64542; Q63127; Q63445; Q64543; Q64544; Q64545;
DT   01-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   27-MAR-2024, entry version 198.
DE   RecName: Full=Plasma membrane calcium-transporting ATPase 4 {ECO:0000305};
DE            Short=PMCA4 {ECO:0000303|PubMed:7702574, ECO:0000303|PubMed:7945253};
DE            EC=7.2.2.10 {ECO:0000250|UniProtKB:P23634};
DE   AltName: Full=Plasma membrane calcium ATPase isoform 4 {ECO:0000303|PubMed:7702574};
DE   AltName: Full=Plasma membrane calcium pump isoform 4 {ECO:0000303|PubMed:7945253};
GN   Name=Atp2b4 {ECO:0000312|RGD:621305};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS XB; ZB; XA AND ZA), AND TISSUE
RP   SPECIFICITY.
RC   STRAIN=CD Charles River; TISSUE=Testis;
RX   PubMed=7702574; DOI=10.1042/bj3060779;
RA   Keeton T.P., Shull G.E.;
RT   "Primary structure of rat plasma membrane Ca(2+)-ATPase isoform 4 and
RT   analysis of alternative splicing patterns at splice site A.";
RL   Biochem. J. 306:779-785(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 266-455 (ISOFORMS XA/XB).
RC   TISSUE=Lung;
RX   PubMed=7945253; DOI=10.1042/bj3030275;
RA   Howard A., Barley N.F., Legon S., Walters J.R.F.;
RT   "Plasma-membrane calcium-pump isoforms in human and rat liver.";
RL   Biochem. J. 303:275-279(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1081-1203, ALTERNATIVE SPLICING
RP   (ISOFORMS XA/ZA), AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=8428948; DOI=10.1016/s0021-9258(18)53836-9;
RA   Keeton T.P., Burk S.E., Shull G.E.;
RT   "Alternative splicing of exons encoding the calmodulin-binding domains and
RT   C termini of plasma membrane Ca(2+)-ATPase isoforms 1, 2, 3, and 4.";
RL   J. Biol. Chem. 268:2740-2748(1993).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-328; SER-334; SER-1064 AND
RP   SER-1070, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1115 AND SER-1126
RP   (ISOFORM XA), PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1103 AND
RP   SER-1114 (ISOFORM ZA), AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Calcium/calmodulin-regulated and magnesium-dependent enzyme
CC       that catalyzes the hydrolysis of ATP coupled with the transport of
CC       calcium out of the cell (By similarity). By regulating sperm cell
CC       calcium homeostasis, may play a role in sperm motility (By similarity).
CC       {ECO:0000250|UniProtKB:P23634, ECO:0000250|UniProtKB:Q6Q477}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + Ca(2+)(in) + H2O = ADP + Ca(2+)(out) + H(+) + phosphate;
CC         Xref=Rhea:RHEA:18105, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:29108, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:456216; EC=7.2.2.10;
CC         Evidence={ECO:0000250|UniProtKB:P23634};
CC   -!- ACTIVITY REGULATION: Activated by calcium/calmodulin.
CC       {ECO:0000250|UniProtKB:P23634}.
CC   -!- SUBUNIT: Interacts with PDZD11. Interacts with SLC35G1 and STIM1.
CC       Interacts with calmodulin. {ECO:0000250|UniProtKB:P23634}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P23634};
CC       Multi-pass membrane protein {ECO:0000255}. Cell projection, cilium,
CC       flagellum membrane {ECO:0000250|UniProtKB:Q6Q477}; Multi-pass membrane
CC       protein {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC         Comment=There is a combination of two alternatively spliced domains
CC         at N-terminal site A (X and Z) and at C-terminal site C (A and B).;
CC       Name=XB; Synonyms=AIICI;
CC         IsoId=Q64542-1; Sequence=Displayed;
CC       Name=XA; Synonyms=AIICII;
CC         IsoId=Q64542-2; Sequence=VSP_000407;
CC       Name=ZA; Synonyms=AICII;
CC         IsoId=Q64542-3; Sequence=VSP_000406, VSP_000407;
CC       Name=ZB; Synonyms=AICI;
CC         IsoId=Q64542-4; Sequence=VSP_000406;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Not detected in liver. The
CC       highest levels are found in uterus and stomach. Isoform XA is found in
CC       uterus, brain, stomach, small intestine, colon and pancreas. Isoform XB
CC       is found in uterus, skeletal muscle, lung, kidney, spleen, stomach,
CC       small intestine and pancreas. Isoform ZA is found in testis and isoform
CC       ZB is found in testis and heart. {ECO:0000269|PubMed:7702574,
CC       ECO:0000269|PubMed:8428948}.
CC   -!- SIMILARITY: Belongs to the cation transport ATPase (P-type) (TC 3.A.3)
CC       family. Type IIB subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U15408; AAA81005.1; -; mRNA.
DR   EMBL; U15408; AAA81006.1; -; mRNA.
DR   EMBL; U15408; AAA81007.1; -; mRNA.
DR   EMBL; U15408; AAA81008.1; -; mRNA.
DR   EMBL; X76452; CAA53990.1; -; mRNA.
DR   EMBL; L05569; AAA50820.1; -; Genomic_DNA.
DR   EMBL; L05566; AAA50820.1; JOINED; Genomic_DNA.
DR   EMBL; L05567; AAA50820.1; JOINED; Genomic_DNA.
DR   PIR; G44525; G44525.
DR   PIR; S50027; S50027.
DR   PIR; S54356; S54356.
DR   PIR; S54357; S54357.
DR   RefSeq; NP_001005871.1; NM_001005871.1. [Q64542-2]
DR   RefSeq; XP_008767668.1; XM_008769446.2. [Q64542-1]
DR   RefSeq; XP_008767669.1; XM_008769447.2.
DR   RefSeq; XP_008767670.1; XM_008769448.2.
DR   RefSeq; XP_008767671.1; XM_008769449.2.
DR   RefSeq; XP_008767672.1; XM_008769450.2.
DR   AlphaFoldDB; Q64542; -.
DR   SMR; Q64542; -.
DR   BioGRID; 248232; 2.
DR   IntAct; Q64542; 2.
DR   MINT; Q64542; -.
DR   STRING; 10116.ENSRNOP00000004078; -.
DR   iPTMnet; Q64542; -.
DR   PhosphoSitePlus; Q64542; -.
DR   jPOST; Q64542; -.
DR   PaxDb; 10116-ENSRNOP00000004078; -.
DR   Ensembl; ENSRNOT00000004078.7; ENSRNOP00000004078.6; ENSRNOG00000003031.8. [Q64542-2]
DR   Ensembl; ENSRNOT00000046273.5; ENSRNOP00000039880.5; ENSRNOG00000003031.8. [Q64542-1]
DR   Ensembl; ENSRNOT00000112237.1; ENSRNOP00000080557.1; ENSRNOG00000003031.8. [Q64542-4]
DR   Ensembl; ENSRNOT00055037372; ENSRNOP00055030456; ENSRNOG00055021793. [Q64542-1]
DR   Ensembl; ENSRNOT00060029863; ENSRNOP00060024075; ENSRNOG00060017440. [Q64542-1]
DR   Ensembl; ENSRNOT00065036088; ENSRNOP00065029095; ENSRNOG00065021200. [Q64542-1]
DR   GeneID; 29600; -.
DR   KEGG; rno:29600; -.
DR   UCSC; RGD:621305; rat. [Q64542-1]
DR   AGR; RGD:621305; -.
DR   CTD; 493; -.
DR   RGD; 621305; Atp2b4.
DR   eggNOG; KOG0204; Eukaryota.
DR   GeneTree; ENSGT00940000154527; -.
DR   InParanoid; Q64542; -.
DR   OMA; MINVHDI; -.
DR   OrthoDB; 847at2759; -.
DR   PhylomeDB; Q64542; -.
DR   Reactome; R-RNO-418359; Reduction of cytosolic Ca++ levels.
DR   Reactome; R-RNO-5578775; Ion homeostasis.
DR   Reactome; R-RNO-936837; Ion transport by P-type ATPases.
DR   PRO; PR:Q64542; -.
DR   Proteomes; UP000002494; Chromosome 13.
DR   Bgee; ENSRNOG00000003031; Expressed in frontal cortex and 20 other cell types or tissues.
DR   Genevisible; Q64542; RN.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0045121; C:membrane raft; ISO:RGD.
DR   GO; GO:0048787; C:presynaptic active zone membrane; IDA:SynGO.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0042383; C:sarcolemma; ISO:RGD.
DR   GO; GO:0036126; C:sperm flagellum; ISO:RGD.
DR   GO; GO:0097228; C:sperm principal piece; IDA:RGD.
DR   GO; GO:0030315; C:T-tubule; ISO:RGD.
DR   GO; GO:0030018; C:Z disc; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro.
DR   GO; GO:0015085; F:calcium ion transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0005516; F:calmodulin binding; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0050998; F:nitric-oxide synthase binding; ISO:RGD.
DR   GO; GO:0036487; F:nitric-oxide synthase inhibitor activity; ISO:RGD.
DR   GO; GO:0005388; F:P-type calcium transporter activity; IDA:RGD.
DR   GO; GO:0030165; F:PDZ domain binding; IPI:RGD.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0030346; F:protein phosphatase 2B binding; ISO:RGD.
DR   GO; GO:0097110; F:scaffold protein binding; ISO:RGD.
DR   GO; GO:1901660; P:calcium ion export; IMP:RGD.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IMP:RGD.
DR   GO; GO:0006816; P:calcium ion transport; IDA:RGD.
DR   GO; GO:1905145; P:cellular response to acetylcholine; ISS:UniProtKB.
DR   GO; GO:0071872; P:cellular response to epinephrine stimulus; ISO:RGD.
DR   GO; GO:0030317; P:flagellated sperm motility; ISS:UniProtKB.
DR   GO; GO:0021766; P:hippocampus development; IEP:RGD.
DR   GO; GO:0006874; P:intracellular calcium ion homeostasis; ISS:UniProtKB.
DR   GO; GO:0071878; P:negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway; ISO:RGD.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; ISO:RGD.
DR   GO; GO:1900082; P:negative regulation of arginine catabolic process; ISO:RGD.
DR   GO; GO:0043537; P:negative regulation of blood vessel endothelial cell migration; ISO:RGD.
DR   GO; GO:0070885; P:negative regulation of calcineurin-NFAT signaling cascade; IMP:BHF-UCL.
DR   GO; GO:1903243; P:negative regulation of cardiac muscle hypertrophy in response to stress; ISO:RGD.
DR   GO; GO:1902548; P:negative regulation of cellular response to vascular endothelial growth factor stimulus; ISO:RGD.
DR   GO; GO:1903249; P:negative regulation of citrulline biosynthetic process; ISO:RGD.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:RGD.
DR   GO; GO:0045019; P:negative regulation of nitric oxide biosynthetic process; ISO:RGD.
DR   GO; GO:0010751; P:negative regulation of nitric oxide mediated signal transduction; ISO:RGD.
DR   GO; GO:0098736; P:negative regulation of the force of heart contraction; ISO:RGD.
DR   GO; GO:0003407; P:neural retina development; IEP:RGD.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; ISO:RGD.
DR   GO; GO:1903078; P:positive regulation of protein localization to plasma membrane; ISO:RGD.
DR   GO; GO:1902806; P:regulation of cell cycle G1/S phase transition; ISO:RGD.
DR   GO; GO:0051480; P:regulation of cytosolic calcium ion concentration; IBA:GO_Central.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0051599; P:response to hydrostatic pressure; ISO:RGD.
DR   GO; GO:0007283; P:spermatogenesis; IEP:RGD.
DR   GO; GO:0014832; P:urinary bladder smooth muscle contraction; ISS:UniProtKB.
DR   CDD; cd02081; P-type_ATPase_Ca_PMCA-like; 1.
DR   Gene3D; 3.40.1110.10; Calcium-transporting ATPase, cytoplasmic domain N; 1.
DR   Gene3D; 2.70.150.10; Calcium-transporting ATPase, cytoplasmic transduction domain A; 1.
DR   Gene3D; 1.20.1110.10; Calcium-transporting ATPase, transmembrane domain; 3.
DR   Gene3D; 3.40.50.1000; HAD superfamily/HAD-like; 1.
DR   InterPro; IPR022141; ATP_Ca_trans_C.
DR   InterPro; IPR006068; ATPase_P-typ_cation-transptr_C.
DR   InterPro; IPR004014; ATPase_P-typ_cation-transptr_N.
DR   InterPro; IPR023299; ATPase_P-typ_cyto_dom_N.
DR   InterPro; IPR018303; ATPase_P-typ_P_site.
DR   InterPro; IPR023298; ATPase_P-typ_TM_dom_sf.
DR   InterPro; IPR008250; ATPase_P-typ_transduc_dom_A_sf.
DR   InterPro; IPR036412; HAD-like_sf.
DR   InterPro; IPR023214; HAD_sf.
DR   InterPro; IPR006408; P-type_ATPase_IIB.
DR   InterPro; IPR001757; P_typ_ATPase.
DR   InterPro; IPR044492; P_typ_ATPase_HD_dom.
DR   NCBIfam; TIGR01517; ATPase-IIB_Ca; 1.
DR   NCBIfam; TIGR01494; ATPase_P-type; 3.
DR   PANTHER; PTHR24093; CATION TRANSPORTING ATPASE; 1.
DR   PANTHER; PTHR24093:SF435; PLASMA MEMBRANE CALCIUM-TRANSPORTING ATPASE 4; 1.
DR   Pfam; PF12424; ATP_Ca_trans_C; 1.
DR   Pfam; PF13246; Cation_ATPase; 1.
DR   Pfam; PF00689; Cation_ATPase_C; 1.
DR   Pfam; PF00690; Cation_ATPase_N; 1.
DR   Pfam; PF00122; E1-E2_ATPase; 2.
DR   Pfam; PF00702; Hydrolase; 1.
DR   PRINTS; PR00119; CATATPASE.
DR   PRINTS; PR00121; NAKATPASE.
DR   SFLD; SFLDG00002; C1.7:_P-type_atpase_like; 1.
DR   SFLD; SFLDF00027; p-type_atpase; 1.
DR   SMART; SM00831; Cation_ATPase_N; 1.
DR   SUPFAM; SSF81653; Calcium ATPase, transduction domain A; 1.
DR   SUPFAM; SSF81665; Calcium ATPase, transmembrane domain M; 1.
DR   SUPFAM; SSF56784; HAD-like; 1.
DR   SUPFAM; SSF81660; Metal cation-transporting ATPase, ATP-binding domain N; 1.
DR   PROSITE; PS00154; ATPASE_E1_E2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Calcium; Calcium transport;
KW   Calmodulin-binding; Cell membrane; Cell projection; Cilium; Flagellum;
KW   Ion transport; Magnesium; Membrane; Metal-binding; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Translocase; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN           1..1203
FT                   /note="Plasma membrane calcium-transporting ATPase 4"
FT                   /id="PRO_0000046221"
FT   TOPO_DOM        1..92
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        93..113
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        114..150
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        151..171
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        172..356
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        357..376
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        377..409
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        410..427
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        428..840
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        841..860
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        861..870
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        871..891
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        892..911
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        912..934
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        935..952
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        953..974
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        975..993
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        994..1015
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1016..1025
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1026..1047
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1048..1203
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          294..319
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          330..349
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1086..1103
FT                   /note="Calmodulin-binding subdomain A"
FT                   /evidence="ECO:0000250|UniProtKB:P20020,
FT                   ECO:0000250|UniProtKB:P23634"
FT   REGION          1104..1113
FT                   /note="Calmodulin-binding subdomain B"
FT                   /evidence="ECO:0000250|UniProtKB:P20020"
FT   COMPBIAS        294..310
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        331..349
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        465
FT                   /note="4-aspartylphosphate intermediate"
FT                   /evidence="ECO:0000250|UniProtKB:P19156"
FT   BINDING         785
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250"
FT   BINDING         789
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         13
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P23634"
FT   MOD_RES         328
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         334
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1064
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1070
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1102
FT                   /note="Phosphothreonine; by PKC"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         1144
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6Q477"
FT   VAR_SEQ         301..312
FT                   /note="Missing (in isoform ZA and isoform ZB)"
FT                   /evidence="ECO:0000303|PubMed:7702574"
FT                   /id="VSP_000406"
FT   VAR_SEQ         1105..1203
FT                   /note="RVVKVFHSFRDVIHKSKNQVSIHSFMTQPEYAADDEMSQSFLNQEESPSLAS
FT                   KSRITKRLSDAETVSQNNTNNNAVDCHQVQIVASHPNSPLQSQETPV -> EVINKFQT
FT                   GASFKGVLRRQNLSQQLDVKLVPSSYSEAVASVRTSPSTSSAVTPPPVGNQSGQSIS
FT                   (in isoform XA and isoform ZA)"
FT                   /evidence="ECO:0000303|PubMed:7702574"
FT                   /id="VSP_000407"
FT   CONFLICT        431
FT                   /note="I -> V (in Ref. 2; CAA53990)"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         Q64542-2:1115
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         Q64542-2:1126
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         Q64542-3:1103
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         Q64542-3:1114
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
SQ   SEQUENCE   1203 AA;  133094 MW;  B7A6C8D4556F6398 CRC64;
     MTNPSGHNLP ANSVAESYEG EFGCTLMDLR KLMELRAADA VTQISAHYGS VQEICARLKT
     SPVEGLSGNP ADLEKRRLVF GKNMIPPKKP KTFLELVWEA LQDVTLIILE IAAIISLVLS
     FYRPPGGENE ICGHIVSNPE EDEEGETGWI EGAAILASVI IVVFVTAFND WSKEKQFRGL
     QSRIELEQKF SIIRNGQLIQ LPVAEIVVGD IAQVKYGDLL PADGILIQGN DLKIDESSLT
     GESDHVKKTL DKDPMLLSGT HVMEGSGRMV VTAVGINSQT GIIFTLLGAN EEEDDEKKKK
     GKKQGVSENR NKAKTQDGVA LEIQPLNSQE GLDSEEKEKK ASKGPKKEKS VLQGKLTRLA
     VQIGKAGLIM SILTVLILIL YFVVDNFVIQ RRAWLPECTP VYIQYFVKFF IIGVTVLVVA
     VPEGLPLAVT ISLAYSVKKM MKDNNLVRHL DACETMGNAT AICSDKTGTL TMNRMTVVQA
     YIGGTHYRQI PKPDDLPPNV LDLIVNSICI NSAYTSKILP PEKEGGLPRQ VGNKTECGLL
     GFVTDLKQDY QAVRSEMPEE KLFKVYTFNS VRKSMSTVIR KPEGGFRVFS KGASEIMLRK
     CDRILNKEGG IVPFKTKDRD NMVRNVIEPM ASEGLRTIGI AYRDFDGEEP SWENENEIFT
     GLVCIAVVGI EDPVRPEVPD AINKCKRAGI TVRMVTGDNV NTARAIATKC GILTPGDDFL
     CLEGKEFNRL IRNEKGEVEQ EKLDKVWPRL RVLARSSPTD KHTLVKGIID SNIGEQRQVV
     AVTGDGTNDG PALKKADVGF AMGIAGTDVA KEASDIILTD DNFTSIVKAV MWGRNVYDSI
     SKFLQFQLTV NVVAVIVAFS GACITQDSPL KAVQMLWVNL IMDTFASLAL ATEPPTDSLL
     RRRPYGRNKP LISRTMMKNI LGHAVYQLGI VFLLVFAGDK LFDIDSGRKA PLNSPPSQHY
     TIVFNTFVLM QLFNEINSRK IHGEKNVFAG VYRNIIFCSV VLGTFFCQIL IVEVGGKPFS
     CTNLTMEQWM WCLFIGIGEL LWGQVISAIP TKSLKFLKEA GHGSDKEEIS KDAEGLEEID
     HAEMELRRGQ ILWVRGLNRI QTQIRVVKVF HSFRDVIHKS KNQVSIHSFM TQPEYAADDE
     MSQSFLNQEE SPSLASKSRI TKRLSDAETV SQNNTNNNAV DCHQVQIVAS HPNSPLQSQE
     TPV
//
DBGET integrated database retrieval system